FoxO1 activation protects against IL-6-mediated perinatal metabolic programming of lung micro-vessels
V. Jentgen (Cologne, Germany), K. Dinger (Cologne, Germany), C. Vohlen (Cologne, Germany), S. Dabral (Bad Nauheim, Germany), J. Will (Cologne, Germany), S. V. Koningsbruggen-Rietschel (Cologne, Germany), M. Odenthal (Cologne, Germany), S. Pullamsetti (Bad Nauheim, Germany), J. Dötsch (Cologne, Germany), M. Alejandre Alcazar (Cologne, Germany)
Source: International Congress 2019 – Molecular and experimental paediatric lung disease
Session: Molecular and experimental paediatric lung disease
Session type: Oral Presentation
Number: 3608
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Jentgen (Cologne, Germany), K. Dinger (Cologne, Germany), C. Vohlen (Cologne, Germany), S. Dabral (Bad Nauheim, Germany), J. Will (Cologne, Germany), S. V. Koningsbruggen-Rietschel (Cologne, Germany), M. Odenthal (Cologne, Germany), S. Pullamsetti (Bad Nauheim, Germany), J. Dötsch (Cologne, Germany), M. Alejandre Alcazar (Cologne, Germany). FoxO1 activation protects against IL-6-mediated perinatal metabolic programming of lung micro-vessels. 3608
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: